John L. Hays

机构：Ohio State University Hospital, The Ohio State University · ORCID：0000-0003-3140-8677

发表论文 249 篇 · 总被引 2330 次 · h-index 27

代表论文

• 10-year follow up of a phase 2 clinical trial of pembrolizumab (pembro) in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 7)
• Consensus Guideline for the Management of Peritoneal Mesothelioma (2025 · Annals of Surgical Oncology · 被引 4)
• Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial (2025 · Clinical Cancer Research · 被引 4)
• Consensus guideline for the management of peritoneal mesothelioma (2025 · Cancer · 被引 2)
• A phase 2 study of the olaparib and AZD6738, an ATM/ATR inhibitor, in isocitrate dehydrogenase (IDH) mutant solid tumors. (2025 · Journal of Clinical Oncology · 被引 1)
• Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patients (2025 · Cancer Causes & Control · 被引 1)